Anti-inflammatory activities of Cassia alata leaf extract in complete freund's adjuvant arthritis in rats

West Indian Medical Journal

Volumn 60, Issue 6, 2011, Pages 615-621

  Lewis, A ^a   Levy, A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Anti inflammatory; Arthritis; Cassia alata; Swelling

Indexed keywords

ANTIINFLAMMATORY AGENT; DICLOFENAC; FREUND ADJUVANT; HEXANE; PLANT EXTRACT; SENNA ALATA EXTRACT; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; INFLAMMATION; KNEE; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; NONHUMAN; PLANT LEAF; RAT; SENNA ALATA; SYNOVIAL FLUID; TREATMENT OUTCOME; ANIMAL; ARTHRITIS; CASSIA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; CASSIA; FEMALE; FREUND'S ADJUVANT; KNEE JOINT; LEUKOCYTE COUNT; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84860832877     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stills H. Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants. ILAR Journal 2005; 46: 280-93.
2. Geboes L, De Klerck B, Van Balen M, Kelchtermans H, Mitera T, Boon L et al. Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis. Arthritis Rheum 2007; 56: 2595-2607.
3. Hirose J, Tanaka S. Animal models for bone and joint disease. CIA, CAIA model. Clin Calcium 2001; 21: 253-9.
4. Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. Journal of Leukocyte Biology 2001; 70: 849-60.
5. Fernand VE, Dinh DT, Washington SJ, Fakayode SO, Losso JN, Van Ravenswaay RO et al. Determination of pharmacologically active compounds in root extracts of Cassia alata L. by use of high performance liquid chromatography. Talanta 2008; 74: 896-902.
6. Damodaran S, Venkataraman SJ. A study on the therapeutic efficacy of cassia alata linn extract against pityriasis vesicolor. J Ethnopharmacol 1994; 42: 19-23.
7. Reezal L, Somchit MN, Abdul Rahim M. In vitro antifungal properties of cassia alata (Gelenggang Besar). Regional Symposium on Environment and Natural Resources 2002; 1: 654-9.
8. Moriyama H. Anti-inflammatory activity of heat treated Cassia alata leaf extract and its flavonoid glycoside. Yakugaku Zasshi 2003; 123: 607-11.
9. Panichayupakaranant P. Distribution of Hydroxyanthracene derivatives in Cassia alata and the factors affecting the quality of raw material. Songklanakarin J Sci Technol 2003; 25: 497-502.
10. Villaseñor IM, Canlas AP, Pascua MP, Sabando MN, Soliven LA. Bioactivity studies on Cassia alata Linn. leaf extracts. Phytother Res 2002; 16 (Suppl 1): 93-6.
11. Choy E, Panayi G. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-14.
12. Fantini F. New drugs and treatment strategies for rheumatoid arthritis. Recenti Prog Med 2003; 94: 361-79.
13. Handa O, Naito Y, Takagi T, Shimozawa M, Kokura S, Yoshida N et al. Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-kappaB. J Pharmacol Exp Ther 2004; 309: 670-6.
14. O'dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004; 350: 2591-602.
15. Rho YH, Oeser A, Chung CP, Milne GL, Stein CM. Drugs used in the treatment of rheumatoid arthritis: relationship between current use and cardiovascular risk factors. Arch Drug Inf 2009; 2: 34-40.
16. Norn S, Permin H, Kruse PR, Kruse E. From willow bark to acetylsalicylic acid. Dan Medicinhist Arbog 2009; 37: 79-98.
17. Moriyama H, Iizuka T, Nagai M, Hoshi K. Adenine, an inhibitor of platelet aggregation, from the leaves of Cassia alata. Biol Pharm Bull 2003; 26: 1361-4.
18. Levy AS, Simon O, Shelly J, Gardener M. 6-shogaol reduced chronic inflammatory response to the knees of rats treated with complete Freund's adjuvant. BMC 2006; B: 12.
19. Schopf LR, Anderson K, Jaffee BD. Rat models of arthritis: similarities, differences, advantages, and disadvantages in identification of novel therapeutics. In: In vivo models of inflammation. 2nd Edition. Progress in Inflammation Research. Basel: Birkhauser Verlag; 2006: 1-34.
20. Yu YC. Two variables that can be used as pain indices in experimental animal models of arthritis. Journal of Neuroscience Methods 2002; 115: 107-113.
21. Bagatini F, Blatt CR,Maliska G, Trespash GV, Pereira IA, Zimmermann AF et al. Potential drug interactions in patients with rheumatoid arthritis. Rev Bras Reumatol 2011; 51: 29-39.
22. Meyer FA, Yaron I, Mashiah V, Yaron M. Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin-1.Br. J Clin Pharmac 1989; 28: 193-6.
23. Ziff M. Pathways of nuclear cell infiltration in rheumatoid arthritis. Rheumatol Int 1989; 9: 97-103.
24. Charo I, Ransohoff R. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-21.
25. Ohsuzu F. The roles of cytokines, inflammation and immunity in vascular diseases. J Atheroscler Thromb 2004; 11: 313-21.
26. Brkic Z, Evelyn D, Olthof, Hemmo A, Drexhage, Marjan A, Versnel. Monocyte gene expression signatures in rheumatoid diseases: biomarkers for disease activity and tools for diagnosis and classification. The Open Arthritis Journal 2010; 3: 13-7.
27. Bauerova K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of RA. Gen Physiol Biophys 1999; 18: 15-20.
28. Van Roon JAG, Bijlsma JWJ, Van de Winkel JGJ, Lafeber FPJG. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FccRI-calicheamic in immunoconjugate. Ann Rheum Dis 2005; 64: 865-70.
29. Rindfleisch MD, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 2005; 72: 1037-47.
30. Syed KM, Pinals RS. Leukocytosis in rheumatoid arthritis. J Clin Rheumatol 1996; 2: 197-202.
31. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002; 110: 651-8.
32. Murrell GA, Dolan MM. Nitric oxide: an important articular free radical. J Bone Joint Surg Am 1996; 78: 265-74.
33. Golding SR. Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol 2002; 65: 44-8.
34. Wu W, Xu X, Dai Y, Xia L. Therapeutic effect of the saponin fraction from Clematis chinensis Osbeck roots on osteoarthritis induced by monosodium iodoacetate through protecting articular cartilage. Phytotherapy Research 2010; 24: 538-48.
35. Bell AL, Adamson H, Kirk F, McCaigue MD, Rotman H. Diclofenac inhibits monocyte superoxide production ex vivo in rheumatoid arthritis. Rheumatol Int 1991; 11: 27-30.